AVA6103 inhibits tumor growth, with complete responses noted in a preclinical treated model engineered with human FAP expression (HEK-FAP) tumors. Increased survival was also shown in this model ...
A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ecosystem of cells, molecules and ...
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede ...
Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, ...
Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, ...
“We and others have previously observed that alterations in STK11 and KEAP1 can promote an immunosuppressive tumor microenvironment and together might be responsible for half or more of the primary ...
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede ...
All breast cancers aren't the same. A specialized doctor called a pathologist learns about each person's breast cancer by ...
Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...
Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, published in the journal Life Science Alliance, allows researchers to study ...
A significant obstacle in treating ovarian cancer is the tumor microenvironment -- the complex ecosystem of cells, molecules and blood vessels that shields cancer cells from the immune system. Within ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback